Click Holdings Limited (NASDAQ:CLIK) Short Interest Update

Click Holdings Limited (NASDAQ:CLIK) was the target of a significant decrease in short interest during the month of March. As of March 13th, there was short interest totaling 451 shares, a decrease of 73.5% from the February 26th total of 1,704 shares. Based on an average daily volume of 196,080 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are sold short. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 196,080 shares, the short-interest ratio is presently 0.0 days.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Click in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Click Stock Performance

Shares of NASDAQ CLIK opened at $1.94 on Wednesday. Click has a one year low of $1.50 and a one year high of $96.00. The business has a 50-day moving average price of $3.77 and a two-hundred day moving average price of $5.95.

About Click

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.